Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new Cochrane Review says Cognitive Behavioural Therapy (CBT) may be effective in reducing the negative impact that tinnitus can have on quality of life.

Researchers from the Cochrane ENT Disorders Group at the Nuffield Department of Surgical Sciences collected and analysed 28 relevant studies (mostly from Europe) with a total of 2733 participants with tinnitus lasting for at least three months. The duration of the CBT ranged from 3 to 22 weeks, mostly given in hospitals or online. CBT was compared with no intervention/waiting list, audiological care, tinnitus retraining therapy (TRT) or another active control (e.g. information, relaxation). However, there is an absence of evidence at 6 or 12 months follow-up. 

The team identified that CBT probably reduces the negative impact of tinnitus on quality of life at the end of treatment compared with audiological care (moderate-certainty evidence), and may reduce it compared with tinnitus retraining therapy, other active controls or no intervention/being on a waiting list (all low-certainty evidence), but it is unknown whether this lasts. CBT may also slightly reduce depression at the end of treatment (low-certainty evidence). 

The Cochrane authors also found some low- to moderate-certainty evidence that adverse effects may be rare in adults with tinnitus receiving CBT, but this needs further investigation. 

Read the full Cochrane Review

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

JNDS: new issue out now

Department Publication

Journal of the Nuffield Department of Surgical Sciences (JNDS) has published its next issue, featuring top case reports written by University of Oxford medical students during their clinical studies.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.